Skip to content
logo_IFAPP_crop
  • About
    • Mission & Objectives
    • Definition of Pharmaceutical Medicine
    • PharmaTrain Syllabus
    • Governance
      • The Board of Officers
      • The House of Delegates
      • The General Assembly
    • Constitution
    • History
      • Council of Past Presidents
  • News
    • News & Posts
    • IFAPP World Newsletter Past Editions
  • IFAPP TODAY
  • Working Groups
    • Communication
    • Education and Certification
    • Ethics
    • External Affairs
    • Young Professionals
  • Collaborations & Partners
  • Events
  • Members and Individual Affiliates
  • Publications
  • Course Marketplace

PharmaTrain Update 31

By Anna Jurczynska | December 16, 2011

Posted in Recent News and tagged PharmaTrain
← Withdrawal Xigris from the market worldwideEMA: Clinical Trials goes live →

Recent Posts

  • IFAPP TODAY | MAY 2023 | NUMBER 34
  • HTA requirements in relation to the EU Regulation. A German perspective
  • Webinar on Clinical Trials in Paediatrics
  • IFAPP TODAY | APRIL 2023 | NUMBER 33
  • Key Principles for Electronic Product Information in the EU

Categories

  • I am IFAPP
  • Recent News

IFAPP secretariat

Leidsestraatweg 41-D

3443 BP WOERDEN

THE NETHERLANDS

Chamber of Commerce: 30224375

Phone: +31 6 2291 1039

E-mail: secretariat@ifapp.org

Privacy Policy

Cookie Policy

logo_icon

Created By: MDM Creative | ©2019